Charles River Laboratories International (CRL) News Today $143.49 +2.11 (+1.49%) As of 05/20/2025 03:59 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock CRL Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Analysts Set Charles River Laboratories International, Inc. (NYSE:CRL) PT at $172.31May 21 at 4:41 AM | americanbankingnews.comCharles River Laboratories International, Inc. (NYSE:CRL) Shares Acquired by Man Group plcMan Group plc boosted its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 359.4% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 82,390 shares of the medicalMay 20 at 5:04 AM | marketbeat.comCharles River Laboratories International, Inc. (NYSE:CRL) Shares Bought by Lazard Asset Management LLCLazard Asset Management LLC raised its stake in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 42.2% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 10,757 shares of tMay 20 at 4:39 AM | marketbeat.comCharles River Laboratories International, Inc. (NYSE:CRL) Given Consensus Rating of "Hold" by BrokeragesShares of Charles River Laboratories International, Inc. (NYSE:CRL - Get Free Report) have earned an average recommendation of "Hold" from the seventeen brokerages that are currently covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell recMay 20 at 2:50 AM | marketbeat.comQuantinno Capital Management LP Raises Stake in Charles River Laboratories International, Inc. (NYSE:CRL)Quantinno Capital Management LP boosted its position in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 78.4% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor ownMay 19 at 5:27 AM | marketbeat.comJanus Henderson Group PLC Boosts Stock Position in Charles River Laboratories International, Inc. (NYSE:CRL)Janus Henderson Group PLC grew its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 22.3% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 5May 19 at 4:34 AM | marketbeat.comCharles River Laboratories International Q1 Earnings TranscriptMay 18 at 7:12 AM | marketbeat.comBaird Financial Group Inc. Reduces Position in Charles River Laboratories International, Inc. (NYSE:CRL)Baird Financial Group Inc. lessened its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 67.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 2,592 shares of the medical research company'sMay 18 at 3:42 AM | marketbeat.comCaptrust Financial Advisors Cuts Stock Holdings in Charles River Laboratories International, Inc. (NYSE:CRL)Captrust Financial Advisors cut its stake in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 23.3% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 6,421 shares ofMay 17, 2025 | marketbeat.comInsider Sell: George Massaro Sells Shares of Charles River Laboratories International IncMay 17, 2025 | gurufocus.comCharles River Laboratories International, Inc. (NYSE:CRL) Director Sells $19,702.20 in StockMay 16, 2025 | insidertrades.comCharles River Laboratories International (NYSE:CRL) Rating Increased to Buy at TD CowenTD Cowen raised Charles River Laboratories International from a "hold" rating to a "buy" rating and set a $179.00 target price on the stock in a research report on Wednesday.May 16, 2025 | marketbeat.comNomura Holdings Inc. Invests $56.82 Million in Charles River Laboratories International, Inc. (NYSE:CRL)Nomura Holdings Inc. bought a new position in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 307,800 shares of theMay 16, 2025 | marketbeat.comNumerai GP LLC Takes $1.59 Million Position in Charles River Laboratories International, Inc. (NYSE:CRL)Numerai GP LLC acquired a new position in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 8,612 shares of the medical research company's stock, valued at approMay 16, 2025 | marketbeat.comDeutsche Bank AG Raises Stock Holdings in Charles River Laboratories International, Inc. (NYSE:CRL)Deutsche Bank AG boosted its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 10.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owneMay 16, 2025 | marketbeat.comBalyasny Asset Management L.P. Makes New $1.05 Million Investment in Charles River Laboratories International, Inc. (NYSE:CRL)Balyasny Asset Management L.P. acquired a new position in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 5,700 shares of the medical research company's stock, valueMay 16, 2025 | marketbeat.comMercer Global Advisors Inc. ADV Sells 1,907 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)Mercer Global Advisors Inc. ADV trimmed its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 43.8% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 2,451May 16, 2025 | marketbeat.comMudita Advisors LLP Cuts Stake in Charles River Laboratories International, Inc. (NYSE:CRL)Mudita Advisors LLP decreased its holdings in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 64.0% in the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 9,607 shares of the medical research company's stock after seMay 15, 2025 | marketbeat.comCharles River Laboratories International, Inc. (NYSE:CRL) Shares Sold by MJP Associates Inc. ADVMJP Associates Inc. ADV decreased its position in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 72.5% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 1,263 shares of the medical research company's stockMay 15, 2025 | marketbeat.comMoore Capital Management LP Purchases Shares of 14,487 Charles River Laboratories International, Inc. (NYSE:CRL)Moore Capital Management LP purchased a new stake in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 14,487 shares of the medicMay 15, 2025 | marketbeat.comJefferies Financial Group Inc. Buys 12,353 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)Jefferies Financial Group Inc. increased its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 226.7% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 17,802 shares of the medical research company's sMay 15, 2025 | marketbeat.comLRT Capital Management LLC Takes Position in Charles River Laboratories International, Inc. (NYSE:CRL)LRT Capital Management LLC purchased a new stake in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund purchased 10,832 shares of the medical research company'May 14, 2025 | marketbeat.comAmeriprise Financial Inc. Acquires 9,847 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)Ameriprise Financial Inc. raised its holdings in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 4.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 223,036 shares of theMay 13, 2025 | marketbeat.comWilliam Blair Has Bullish Forecast for CRL Q2 EarningsCharles River Laboratories International, Inc. (NYSE:CRL - Free Report) - Investment analysts at William Blair raised their Q2 2025 earnings per share estimates for Charles River Laboratories International in a report issued on Wednesday, May 7th. William Blair analyst M. Smock now anticipates thMay 13, 2025 | marketbeat.comWilliam Blair Issues Positive Forecast for CRL EarningsMay 13, 2025 | americanbankingnews.comRep. Robert Bresnahan, Jr. Buys Charles River Laboratories International, Inc. (NYSE:CRL) StockRepresentative Robert Bresnahan, Jr. (R-Pennsylvania) recently bought shares of Charles River Laboratories International, Inc. (NYSE:CRL). In a filing disclosed on May 08th, the Representative disclosed that they had bought between $15,001 and $50,000 in Charles River Laboratories International stoMay 12, 2025 | marketbeat.comGotham Asset Management LLC Has $22.83 Million Position in Charles River Laboratories International, Inc. (NYSE:CRL)Gotham Asset Management LLC raised its stake in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 59.9% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 123,690 shares of the medical research company's stock after bMay 12, 2025 | marketbeat.comBank of America Corp DE Sells 157,964 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)Bank of America Corp DE lowered its position in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 16.1% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 822,8May 12, 2025 | marketbeat.comBNP Paribas Financial Markets Grows Holdings in Charles River Laboratories International, Inc. (NYSE:CRL)BNP Paribas Financial Markets lifted its stake in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 13.8% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 90,083 shares of theMay 12, 2025 | marketbeat.comCharles River Laboratories International, Inc. (NYSE:CRL) Shares Bought by FORA Capital LLCFORA Capital LLC increased its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 50.3% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 9,060 shares of the medical research company's stock after puMay 11, 2025 | marketbeat.comCharles River Laboratories International, Inc. (NYSE:CRL) Stock Holdings Trimmed by Comerica BankComerica Bank trimmed its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 19.6% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 13,246 shares of the medical research company's stock after selling 3May 11, 2025 | marketbeat.comCharles River Laboratories International (NYSE:CRL) Stock Price Expected to Rise, Robert W. Baird Analyst SaysRobert W. Baird lifted their price target on shares of Charles River Laboratories International from $118.00 to $140.00 and gave the company a "neutral" rating in a research note on Thursday.May 10, 2025 | marketbeat.comActivist Elliott reaches key agreement with Charles River. Here are three ways to create valueMay 10, 2025 | cnbc.comCharles River Laboratories International (NYSE:CRL) Upgraded at Evercore ISIEvercore ISI upgraded Charles River Laboratories International from an "in-line" rating to an "outperform" rating and set a $170.00 price objective on the stock in a research report on Thursday.May 10, 2025 | marketbeat.comCharles River Laboratories International (NYSE:CRL) Shares Gap Up on Earnings BeatCharles River Laboratories International (NYSE:CRL) Shares Gap Up on Earnings BeatMay 9, 2025 | marketbeat.comCharles River Laboratories International (NYSE:CRL) Releases FY 2025 Earnings GuidanceCharles River Laboratories International (NYSE:CRL) updated its FY 2025 earnings guidance. The company provided EPS guidance of 9.300-9.800 for the period, compared to the consensus estimate of 9.310. The company also issued revenue guidance of $3.8 billionillion-$3.9 billionillion, compared to the consensus estimate of $3.8 billionillion.May 9, 2025 | marketbeat.comCharles River Laboratories International, Inc. (NYSE:CRL) Stock Position Lowered by Eminence Capital LPEminence Capital LP trimmed its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 37.5% during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 627,472 shares of the medical research coMay 9, 2025 | marketbeat.comCharles River Laboratories International, Inc. (NYSE:CRL) Holdings Raised by Centiva Capital LPCentiva Capital LP increased its stake in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 58.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 11,511 shares of the medical research company's sMay 9, 2025 | marketbeat.comCharles River Laboratories International, Inc. (NYSE:CRL) Stock Position Boosted by Brevan Howard Capital Management LPBrevan Howard Capital Management LP lifted its stake in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 90.0% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 8,008 shares of the mediMay 9, 2025 | marketbeat.comCharles River extends gains as Evercore upgrades after Q1 beatMay 8, 2025 | msn.comCharles River Laboratories International Inc (CRL) Q1 2025 Earnings Call Highlights: Navigating ...May 8, 2025 | gurufocus.comCharles River agrees with Elliott to add new directors, review businessMay 7, 2025 | msn.comS&P 500 Gains & Losses Today: Stocks Gain in Volatile Session as Markets React to Fed Meeting, Trump Trade CommentsMay 7, 2025 | investopedia.comCharles River Laboratories International, Inc. (CRL) Q1 2025 Earnings Call TranscriptMay 7, 2025 | seekingalpha.comCharles River Labs Stock Soars as Firm Shakes Up Board, Launches ReviewMay 7, 2025 | msn.comCharles River announces strategic review including 'examination of various alternatives'May 7, 2025 | msn.comCharles River Stock Is Having Its Best Day in 13 Years. A Board Shake-Up and Business Review Will Help.May 7, 2025 | barrons.comTop Stock Moves Now: Charles River Labs, Disney, Supermicro, and MoreMay 7, 2025 | investopedia.comCharles River shares surge on governance updates and strong Q1 earningsMay 7, 2025 | in.investing.comCharles River to add new directors, review business in agreement with ElliottMay 7, 2025 | reuters.com Get Charles River Laboratories International News Delivered to You Automatically Sign up to receive the latest news and ratings for CRL and its competitors with MarketBeat's FREE daily newsletter. Email Address CRL Media Mentions By Week CRL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CRL News Sentiment▼1.220.65▲Average Medical News Sentiment CRL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CRL Articles This Week▼2510▲CRL Articles Average Week Get Charles River Laboratories International News Delivered to You Automatically Sign up to receive the latest news and ratings for CRL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Mettler-Toledo International News Waters News Illumina News Bio-Techne News Bio-Rad Laboratories News Bruker News Pacific Biosciences of California News Harvard Bioscience News Thermo Fisher Scientific News Agilent Technologies News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:CRL) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredMan who predicted $100K Bitcoin sees a huge run coming for another coin …Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election...Weiss Ratings | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Charles River Laboratories International, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Charles River Laboratories International With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
